Investing

5 Big Earning Beats Making These Stocks a Buy

When a company beats earnings estimates, investors often pile into it. But not all earnings beats are created equal. Twilio (NYSE:TWLO) announced large layoffs and told analysts to expect bad numbers, then beat them. Microsoft (NASDAQ:MSFT) showed big gains in the cloud, but it’s losing its biggest franchise in Windows. SunPower (NASDAQ:SPWR) beat estimates, but not by enough to […]

5 Big Earning Beats Making These Stocks a Buy Read More »

7 Must-Buy Penny Stocks to Add to Your Portfolio in 2023

For anyone interested in must-buy penny stocks to add to your portfolio in 2023, the framework comes down to a single concept: high risk, and high rewards. To be sure, anyone venturing into this space must acknowledge that the sector represents a gamble. With limited awareness and participation, these penny stocks may skyrocket at a moment’s

7 Must-Buy Penny Stocks to Add to Your Portfolio in 2023 Read More »

Goldman on Federal Reserve: Another 75 Bps Hike From Here More Likely

[embedded content] Jan Hatzius, chief economist and head of global investment research at Goldman Sachs, talks about the outlook for the US economy and Federal Reserve policy. The team led by Hatzius has cut its estimate for the probability of a US recession in the next 12 months to 25% from 35%. Hatzius also discusses

Goldman on Federal Reserve: Another 75 Bps Hike From Here More Likely Read More »

3 Overlooked Penny Stocks That Could Be the Next Big Thing

During the penny stocks euphoria in 2021, these stocks were largely linked to speculative activity. It’s, however, a myth that penny stocks are nothing beyond trading or speculating bets. There are exciting stories among low-priced stocks that can become big in the coming years. Therefore, I would pursue deeper research into some of the overlooked penny stocks

3 Overlooked Penny Stocks That Could Be the Next Big Thing Read More »

3 Large-Cap Biotech Stocks to Hold for the Long Haul

Despite the sharp slide in biotech stocks during 2022, the industry is still poised for mega growth.  Pandemic preparedness needs better vaccines and disease detection methods.  An aging population needs new drugs and new ways to use them. Plus, new technologies like CRISPR have given scientists the tools they need to make this all happen. The

3 Large-Cap Biotech Stocks to Hold for the Long Haul Read More »